scholarly journals The longer the antithyroid drug is used, the lower the relapse rate in Graves’ disease: a retrospective multicenter cohort study in Korea

Endocrine ◽  
2021 ◽  
Author(s):  
So Young Park ◽  
Bo Hyun Kim ◽  
Mijin Kim ◽  
A.Ram Hong ◽  
Jun Park ◽  
...  
Keyword(s):  
Cohort Study ◽  
Relapse Rate ◽  
Antithyroid Drug ◽  
Graves Disease ◽  
Multicenter Cohort Study ◽  
Multicenter Cohort

scholarly journals The Longer the Antithyroid Drug Is Used, the Lower the Relapse Rate in Graves' Disease: a Retrospective Multicenter Cohort Study in Korea

2021 ◽  
Author(s):  
So Young Park ◽  
Bo Hyun Kim ◽  
Mijin Kim ◽  
A Ram Hong ◽  
Jun Park ◽  
...  
Keyword(s):  
Cohort Study ◽  
Relapse Rate ◽  
Treatment Duration ◽  
Cox Regression ◽  
Antithyroid Drug ◽  
Graves Disease ◽  
Multicenter Cohort Study ◽  
Cox Regression Analysis ◽  
One Year

Abstract Purpose: Current literature suggests 12 to 18 months of antithyroid drug (ATD) treatment for patients with Graves’ disease, but the risk of relapse is high. Although some studies reported better outcomes of long-term ATD treatment, recent data that suggest the optimal treatment duration are limited.Methods: We performed a multicenter retrospective cohort study of 908 patients newly diagnosed with Graves’ disease between 2006 and 2013. The relapse rate according to ATD treatment duration was analyzed.Results: After initial ATD treatment, 338 patients (37.2%) had relapsed. The relapse rate according to ATD treatment duration was 42.4% at one year, 38.5% at two years, 33.8% at three years, 31.7% at four years, 30.2% at five years, 27.8% at six years, and 19.1% at more than six years, respectively, demonstrating a significant decreasing trend (P = 0.003). In a multivariable Cox regression analysis, ATD treatment duration was an independent risk factor for relapse (P = 0.043).Conclusions: The longer that ATD therapy is used, the lower the relapse rate is in patients with Graves' disease. Long-term ATD treatment may be considered in Graves’ patients who do not show complications or an economic burden from hyperthyroidism.

Early Discern COVID-19 from the Suspected Patients via Fever Clinics: A Multicenter Cohort Study from Shanghai

2020 ◽  
Author(s):  
Bei Mao ◽  
Yang Liu ◽  
Yan-hua Chai ◽  
Xiao-yan Jin ◽  
Hai Wen Luo ◽  
...  
Keyword(s):  
Cohort Study ◽  
Multicenter Cohort Study ◽  
Multicenter Cohort

Evaluation of the effectiveness of antenatal corticoid in preterm twin and single pregnancies: a multicenter cohort study

2021 ◽  
pp. 1-7
Author(s):  
Walusa Assad Gonçalves-Ferri ◽  
Francisco Eulógio Martinez ◽  
Fábia Pereira Martins-Celini ◽  
João Henrique Carvalho Leme de Almeida ◽  
Renato Procianoy ◽  
...  
Keyword(s):  
Cohort Study ◽  
Multicenter Cohort Study ◽  
Multicenter Cohort

Risk factors for cancer‐associated myositis: A large‐scale multicenter cohort study

2020 ◽  
Author(s):  
Yimin Li ◽  
Xiaohui Jia ◽  
Xiaolin Sun ◽  
Lianjie Shi ◽  
Fuan Lin ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cohort Study ◽  
Large Scale ◽  
Multicenter Cohort Study ◽  
Multicenter Cohort
Sign in / Sign up

Export Citation Format

Share Document